Navigation Links
Amarin in Medical News

RNA engineering to combat series of illnesses wins Kaye Award for Hebrew University dean

...profile and dosing regimen, as compared with the currently used drug, which targets the protein. In December 2007, Ester Neurosciences was acquired by amarin Corporation plc, a Nasdaq listed UK company. ...

Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations

...program operations in international territories for Alexza's product candidates. Dr. Clarke was most recently Vice President, Clinical Development for amarin Corporation, based in the United Kingdom. Prior to Amarin, Dr. Clarke held positions as Director, Clinical Development and Independent Consultant fo...

Amarin Announces Private Placement for up to $60 Million

... DUBLIN, May 14 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced a...ly over the next 12 months. Certain directors of amarin have indicated an interest in investing up to an a...eve reflects the attractive investment proposition amarin represents." The Company intends to use the proc...

Amarin Regains Compliance With Nasdaq Listing Requirements

... LONDON, February 11 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRND ) today announced ...trengthened our management team." About Amarin amarin is committed to improving the lives of patients su...son's disease; one in epilepsy; and one in memory. amarin is initiating a series of cardiovascular preclinic...

Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program

...ng LONDON, November 29 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t... our progress with these exciting new programs." amarin intends to develop its dyslipidemia and metabolic ...unsaturated fatty acids in cardiovascular disease. amarin plans to utilize its extensive know-how, intellect...

Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntington's Disease Program

... LONDON, November 19 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) ("Amarin" or "Com...zed to treatment with Miraxion at baseline. About amarin amarin is committed to improving the lives of patients su...

Pharmacopeia Announces Senior Additions to Management Team

...Senior Vice President, Strategic Planning at Questcor Pharmaceuticals and held executive-level positions with Enzon Pharmaceuticals, Elan Corporation, amarin Pharmaceuticals, and Athena Neurosciences. Mr. Liebler currently serves as Vice Chairman of the Board of Trustees of the American Academy of Neurology...
Amarin in Medical Technology

Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia

...DUBLIN, Ireland, July 22 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t... ethyl ester of eicosapentaenoic acid (Ethyl-EPA). amarin has collected a substantial body of data on AMR101 to date. amarin has previously investigated AMR101 in central nerv...

Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease

...n both the U.S. and in Europe. Conference Call amarin management will host a conference call to discuss ...natural history and interventional trials. About amarin amarin is committed to improving the lives of patients su...
Amarin in Biological Technology

Amarin Announces Completion of the First Tranche of $60 Million Private Placement

...o Board DUBLIN, May 22 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t... $27 million. In conjunction with the financing, amarin has appointed to its Board representatives of the ...Capital. Non-executive directors retiring from the amarin Board are Mr. John Groom, Dr. Simon Kukes, Dr. Pre...

Amarin Announces Financial Results for Fourth Quarter and Full Year 2007

... DUBLIN, Ireland, May 19 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) ("Amarin" or "Com...December 31, 2007. For the fourth quarter of 2007, amarin reported a net loss of $7.9 million, or $0.72 per ...ion costs. For the year ended December 31, 2007, amarin reported a net loss of $38.2 million or $3.90 per ...

Amarin Secures Global Intellectual Property Rights for Lipid Programs

... LONDON, March 3 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t...n and royalties upon commercialization. In 2004, amarin licensed rights to this portfolio, covering applic...erica, the EU and Japan. This new license provides amarin with rights to all remaining therapeutic areas and...

Amarin Appoints Dr. William Mason as Lead Independent Director

... LONDON, February 4 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRND ) today announced ...o that position follows the recent announcement by amarin that Thomas Lynch, Amarin's Chairman, has assumed ...ason has served as a non-executive board member of amarin since July 2002, is Chairman of the Company's Audi...

Amarin Provides Business Update and Announces Implementation of Reverse Stock Split

... LONDON, January 18 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRND ) today announced ...iness yesterday, January 17, 2008. Thomas Lynch, amarin Chairman and Chief Executive Officer, commented "W...rom the U.S. Food and Drug Administration (FDA). amarin also conducted a thorough analysis and re-configur...

Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment

... LONDON, January 10 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t...n all developed nations with aging populations." amarin had previously announced positive results from a p...ls who do not meet AAMI criteria. About Amarin amarin is committed to improving the lives of patients su...

Amarin Signs Agreement to Acquire Ester Neurosciences

...008 LONDON, December 5 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t... strategic fit for Amarin. This acquisition allows amarin to gain access to a unique mRNA platform technolog...on Preparations for the integration of Ester and amarin have already begun....

Amarin Corporation to Present at Acumen BioFin Rodman & Renshaw Ninth Annual Healthcare Conference

... LONDON, October 31 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) ("Amarin" or the ...ultaneously webcast and a link will be provided on amarin Corporation's website http://www.amarincorp.com . About amarin ...

Amarin Announces Initiation of Cardiovascular Development Strategy

...ase LONDON, October 10 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t...unsaturated fatty acids in cardiovascular disease. amarin plans to utilize its extensive know-how and experi... added value from our lipid technology platform." amarin intends to commence a series of clinical trials wi...

Amarin to Present at 4th Annual Bio Investor Forum

... LONDON, October 9 /PRNewswire-FirstCall/ -- amarin Corporation plc (NASDAQ: AMRN ) today announced t...ultaneously webcast and a link will be provided on amarin Corporation's website http://www.amarincorp.com . About amarin ...
Other Tags
(Date:9/2/2014)... the groundwork for their own spread throughout the body ... tumor-welcoming signals, according to a new report by Johns ... of Nature Communications , the researchers describe animal ... signaling molecules released by breast cancer cells. These molecules ... lymph nodes to produce proteins called CCL5 and VEGF. ...
(Date:9/2/2014)... Melbourne, Australia (PRWEB) September 03, 2014 ... Australia attend to millions of people annually, arranging care ... subdivision's not-for-profit and private enterprises are expected to derive ... government funding, donations and private income. Over the five ... at an annualised rate of 6.6%, including growth of ...
(Date:9/2/2014)... 2014 (HealthDay News) -- Melatonin supplements did not reduce ... a new study found. Many older hospital patients ... to disruption of their normal sleep-wake cycle. A lack ... contributes to delirium, but there has been little research ... This study included 378 patients, average age 84, who ...
(Date:9/2/2014)... Steven Reinberg HealthDay Reporter ... the Ebola outbreak continues to overwhelm health-care workers in ... States and the United Nations called on Tuesday for ... of the often-fatal virus. Dr. Thomas Frieden, director ... said that without a greater global commitment in resources ...
(Date:9/2/2014)... Albany, New York (PRWEB) September 02, 2014 ... lucrative business with products and services such as ... color, radio frequency-device based treatments, and breast augmentation ... market report published by U.S.-based market intelligence firm ... anti-aging treatments and products will grow to USD ...
Breaking Medicine News(10 mins):Health News:‘Prepped’ by tumor cells, lymphatic cells encourage breast cancer cells to spread 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:More Global Help Needed to Fight Ebola Outbreak 2Health News:More Global Help Needed to Fight Ebola Outbreak 3Health News:Global Anti-aging Market Research Report 2018 by Transparency Market Research 2Health News:Global Anti-aging Market Research Report 2018 by Transparency Market Research 3
(Date:9/2/2014)... of Human Genetics (ASHG) and the National Human ... Institutes of Health, have named Katherine D. Blizinsky, ... the newest ASHG/NHGRI Genetics and Public Policy Fellow. ... and Public Policy Fellowship is intended to help ... and research policy at a national level. Fellows ...
(Date:9/2/2014)... digital distribution of media will have lower carbon ... when file sizes are large. , That,s the ... Journal of Industrial Ecology that looked at ... as PlayStation3. Researchers found that Blu-ray Discs delivered ... than game files downloaded over broadband Internet. For ...
(Date:9/2/2014)... baseball pitchers with poor core stability are more likely to ... of injury than are pitchers who have good control of ... study, 347 pitchers were assessed for lumbopelvic control during spring ... raised a leg to step up were up to three ... cumulative, not consecutive during the season than were pitchers ...
Breaking Biology News(10 mins):ASHG and NHGRI award genetics and public policy fellowship 2In pro baseball pitchers, weak core linked to more missed days 2In pro baseball pitchers, weak core linked to more missed days 3
Other Contents